• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Announcements


ACW Actinogen Medical Investor Presentation09/09/20 download Created with Sketch. 1.33MB
ACW Appendix 4G26/08/20 download Created with Sketch. 198.16KB
ACW Appendix 4E & Annual ReportPRICE SENSITIVE26/08/20 download Created with Sketch. 1.05MB
ACW Quarterly Activity Report & Appendix 4CPRICE SENSITIVE29/07/20 download Created with Sketch. 331.08KB
ACW Response to ASX Price QueryPRICE SENSITIVE01/07/20 download Created with Sketch. 254.37KB
ACW Market Update and ACW to Participate in BIO Digital04/06/20 download Created with Sketch. 207.6KB
ACW Actinogen Presentation at AAT-ADPD International Congress29/04/20 download Created with Sketch. 161.59KB
ACW Quarterly Activity Report & Appendix 4CPRICE SENSITIVE23/04/20 download Created with Sketch. 228.75KB
ACW Actinogen presents latest Xanamem data at AD Conference01/04/20 download Created with Sketch. 233.48KB
ACW Market Update COVID-19PRICE SENSITIVE26/03/20 download Created with Sketch. 159.31KB
ACW Appendix 4D & Half-Year Financial StatementsPRICE SENSITIVE20/02/20 download Created with Sketch. 789.69KB
ACW Additional R&D Tax Incentive rebate received17/02/20 download Created with Sketch. 154.36KB
ACW Appendix 3Y-Dr Bill Ketelbey31/01/20 download Created with Sketch. 26.99KB
ACW ASIC Form 48431/01/20 download Created with Sketch. 123.27KB
ACW Final share buy-back notice - Appendix 3F31/01/20 download Created with Sketch. 282.79KB
ACW December 2019 Quarterly UpdatePRICE SENSITIVE28/01/20 download Created with Sketch. 368.91KB
ACW Actinogen at SACHS Forum and JP Morgan week08/01/20 download Created with Sketch. 2.31MB
ACW Review of 2019 and outlook18/12/19 download Created with Sketch. 167.14KB
ACW Share Cancellation - Employee Share Plan13/12/19 download Created with Sketch. 340.7KB
ACW Managing Director share loan repayment27/11/19 download Created with Sketch. 182.95KB
ACW Results of Annual General Meeting25/11/19 download Created with Sketch. 196.92KB
ACW Managing Director's AGM Presentation25/11/19 download Created with Sketch. 2.43MB
ACW ACW 2019 AGM Chairman's Address25/11/19 download Created with Sketch. 166.6KB
ACW Response to ASX Price QueryPRICE SENSITIVE20/11/19 download Created with Sketch. 272.08KB
ACW R&D Tax Incentive rebate received of $4.58 millionPRICE SENSITIVE24/10/19 download Created with Sketch. 140.48KB
ACW September 2019 Quarterly UpdatePRICE SENSITIVE24/10/19 download Created with Sketch. 302.11KB
ACW Annual Report to shareholders22/10/19 download Created with Sketch. 1.79MB
ACW Notice of Annual General Meeting/Proxy Form22/10/19 download Created with Sketch. 794.26KB
ACW Cognitive improvement demonstrated with XanamemPRICE SENSITIVE01/10/19 download Created with Sketch. 2.63MB
ACW Actinogen Medical Conference Call30/09/19 download Created with Sketch. 132.63KB
ACW Notification of 2019 Annual General Meeting Date27/09/19 download Created with Sketch. 130.78KB
ACW Trading HaltPRICE SENSITIVE27/09/19 download Created with Sketch. 232.45KB
ACW Appendix 4G16/08/19 download Created with Sketch. 101.3KB
ACW Appendix 4E & Annual ReportPRICE SENSITIVE16/08/19 download Created with Sketch. 1.79MB
ACW June 2019 Quarterly UpdatePRICE SENSITIVE30/07/19 download Created with Sketch. 237.23KB
ACW Clinical Development and Scientific Conference Update03/07/19 download Created with Sketch. 141.45KB
ACW Xanamen Clinical Development & Investor UpdatePRICE SENSITIVE26/06/19 download Created with Sketch. 2.47MB
ACW Actingoen Medical participating in the BIO 2019 Convention03/06/19 download Created with Sketch. 142.86KB
ACW XanaHES Trial to ContinuePRICE SENSITIVE29/05/19 download Created with Sketch. 142.12KB
ACW Ceasing to be a substantial holder10/05/19 download Created with Sketch. 181.92KB
ACW Ceasing to be a substantial holder from AEF08/05/19 download Created with Sketch. 430.49KB
ACW Phase II Alzheimer's Disease Trial - resultsPRICE SENSITIVE07/05/19 download Created with Sketch. 145.16KB
ACW Trading HaltPRICE SENSITIVE03/05/19 download Created with Sketch. 234.39KB
ACW Actinogen Updated Investor Presentation01/05/19 download Created with Sketch. 3.53MB
ACW March 2019 Quarterly UpdatePRICE SENSITIVE24/04/19 download Created with Sketch. 295.74KB
ACW Change in substantial holding23/04/19 download Created with Sketch. 200.93KB
ACW Lapse of Options15/04/19 download Created with Sketch. 133.07KB
ACW Appendix 3Y-Mr Malcolm McComas12/04/19 download Created with Sketch. 25.82KB
ACW Appendix 3B12/04/19 download Created with Sketch. 156.69KB
ACW New Clinical Development Opportunities for XanamemPRICE SENSITIVE10/04/19 download Created with Sketch. 141.79KB
ACW Cleansing Notice04/04/19 download Created with Sketch. 100.42KB
ACW Appendix 3B04/04/19 download Created with Sketch. 153.44KB
ACW Appendix 3X-Malcolm McComas04/04/19 download Created with Sketch. 66.89KB
ACW Actinogen Medical appoints new Non-Executive Director04/04/19 download Created with Sketch. 134.24KB
ACW DSMB again reaffirms XanADu trial to continue without changePRICE SENSITIVE26/03/19 download Created with Sketch. 135.23KB
ACW Change in substantial holding (Replacement Form 604)22/03/19 download Created with Sketch. 274.83KB
ACW Change in substantial holding22/03/19 download Created with Sketch. 244.57KB
ACW Actinogen Updated Investor Presentation21/03/19 download Created with Sketch. 2.88MB
ACW Appendix 3B19/03/19 download Created with Sketch. 159.03KB
ACW Becoming a substantial holder14/03/19 download Created with Sketch. 304.67KB
ACW Amended-Notification of Expiry of Listed Options04/03/19 download Created with Sketch. 205.14KB
ACW Notification of Expiry of Listed Options27/02/19 download Created with Sketch. 154.77KB
ACW Appendix 4D & Half-Year Financial StatementsPRICE SENSITIVE22/02/19 download Created with Sketch. 671.9KB
ACW 1st participant dosed in important new Xanamem study-XanaHESPRICE SENSITIVE11/02/19 download Created with Sketch. 137.29KB
ACW Appendix 3B04/02/19 download Created with Sketch. 153.92KB
ACW December 2018 Quarterly UpdatePRICE SENSITIVE29/01/19 download Created with Sketch. 237.64KB
ACW ACW Presents at SACHS Neuroscience Forum during JPM Week07/01/19 download Created with Sketch. 2.79MB
ACW Appendix 3Y-Dr George Morstyn13/12/18 download Created with Sketch. 26.42KB
ACW Appendix 3Y-Dr Bill Ketelbey13/12/18 download Created with Sketch. 26.34KB
ACW Appendix 3y-Dr Geoff Brooke13/12/18 download Created with Sketch. 26.62KB
ACW Appendix 3B13/12/18 download Created with Sketch. 155.42KB
ACW Cleansing Notice30/11/18 download Created with Sketch. 99.75KB
ACW Appendix 3B-Exercise of Options30/11/18 download Created with Sketch. 159.29KB
ACW Appendix 3Z-Dr Jason Loveridge28/11/18 download Created with Sketch. 26.74KB
ACW Retirement of Dr Jason Loveridge as a Non-Executive Director28/11/18 download Created with Sketch. 131.66KB
ACW Results of Annual General Meeting28/11/18 download Created with Sketch. 189.04KB
ACW Managing Director's AGM Presentation28/11/18 download Created with Sketch. 1.17MB
ACW Chairman's AGM Address28/11/18 download Created with Sketch. 89.83KB
ACW Final patient enrolled in landmark Alzheimer's trial-XanADuPRICE SENSITIVE26/11/18 download Created with Sketch. 132.3KB
ACW Actinogen updated investor presentation26/11/18 download Created with Sketch. 2.82MB
ACW Cleansing Notice14/11/18 download Created with Sketch. 99.78KB
ACW Appendix 3B-Exercise of Options14/11/18 download Created with Sketch. 159.68KB
ACW Supportive research highlights cortisol hypothesis08/11/18 download Created with Sketch. 179.93KB
ACW September 2018 Quarterly UpdatePRICE SENSITIVE31/10/18 download Created with Sketch. 238.76KB
ACW Vesting Conditions Met31/10/18 download Created with Sketch. 130.33KB
ACW Actinogen to be showcased at AusBiotech Invest 201830/10/18 download Created with Sketch. 694.34KB
ACW Enrolment target achieved for major Alzheimer's trial-XanADu29/10/18 download Created with Sketch. 132.73KB
ACW XanADu trial to be presented at global Alzheimer conference24/10/18 download Created with Sketch. 138.03KB
ACW Annual Report to Shareholders23/10/18 download Created with Sketch. 1.56MB
ACW Notice of Annual General Meeting/Proxy Form23/10/18 download Created with Sketch. 463.61KB
ACW Recruitment to close for important Alzheimer's trial-XanADuPRICE SENSITIVE22/10/18 download Created with Sketch. 134.26KB
ACW Actinogen to be showcased at key conferences17/10/18 download Created with Sketch. 1.24MB
ACW Becoming a substantial holder from AEF16/10/18 download Created with Sketch. 440.95KB
ACW R&D Tax Rebate Received Totalling $3.15 MillionPRICE SENSITIVE10/10/18 download Created with Sketch. 138.04KB
ACW Notification of 2018 Annual General Meeting Date28/09/18 download Created with Sketch. 127.19KB
ACW Cleansing Notice18/09/18 download Created with Sketch. 99.77KB
ACW Appendix 3B-Exercise of Options18/09/18 download Created with Sketch. 160.45KB
ACW Actinogen to Present to Investors in Singapore & Sydney11/09/18 download Created with Sketch. 1.56MB
ACW Appendix 4G29/08/18 download Created with Sketch. 109.87KB
ACW Appendix 4E & Financial StatementsPRICE SENSITIVE29/08/18 download Created with Sketch. 1.56MB
ACW Actinogen Medical Investor Presentation
09/09/20 download Created with Sketch. 1.33MB
ACW Appendix 4G
26/08/20 download Created with Sketch. 198.16KB
ACW Appendix 4E & Annual Report
26/08/20PRICE SENSITIVE download Created with Sketch. 1.05MB
ACW Quarterly Activity Report & Appendix 4C
29/07/20PRICE SENSITIVE download Created with Sketch. 331.08KB
ACW Response to ASX Price Query
01/07/20PRICE SENSITIVE download Created with Sketch. 254.37KB
ACW Market Update and ACW to Participate in BIO Digital
04/06/20 download Created with Sketch. 207.6KB
ACW Actinogen Presentation at AAT-ADPD International Congress
29/04/20 download Created with Sketch. 161.59KB
ACW Quarterly Activity Report & Appendix 4C
23/04/20PRICE SENSITIVE download Created with Sketch. 228.75KB
ACW Actinogen presents latest Xanamem data at AD Conference
01/04/20 download Created with Sketch. 233.48KB
ACW Market Update COVID-19
26/03/20PRICE SENSITIVE download Created with Sketch. 159.31KB
ACW Appendix 4D & Half-Year Financial Statements
20/02/20PRICE SENSITIVE download Created with Sketch. 789.69KB
ACW Additional R&D Tax Incentive rebate received
17/02/20 download Created with Sketch. 154.36KB
ACW Appendix 3Y-Dr Bill Ketelbey
31/01/20 download Created with Sketch. 26.99KB
ACW ASIC Form 484
31/01/20 download Created with Sketch. 123.27KB
ACW Final share buy-back notice - Appendix 3F
31/01/20 download Created with Sketch. 282.79KB
ACW December 2019 Quarterly Update
28/01/20PRICE SENSITIVE download Created with Sketch. 368.91KB
ACW Actinogen at SACHS Forum and JP Morgan week
08/01/20 download Created with Sketch. 2.31MB
ACW Review of 2019 and outlook
18/12/19 download Created with Sketch. 167.14KB
ACW Share Cancellation - Employee Share Plan
13/12/19 download Created with Sketch. 340.7KB
ACW Managing Director share loan repayment
27/11/19 download Created with Sketch. 182.95KB
ACW Results of Annual General Meeting
25/11/19 download Created with Sketch. 196.92KB
ACW Managing Director's AGM Presentation
25/11/19 download Created with Sketch. 2.43MB
ACW ACW 2019 AGM Chairman's Address
25/11/19 download Created with Sketch. 166.6KB
ACW Response to ASX Price Query
20/11/19PRICE SENSITIVE download Created with Sketch. 272.08KB
ACW R&D Tax Incentive rebate received of $4.58 million
24/10/19PRICE SENSITIVE download Created with Sketch. 140.48KB
ACW September 2019 Quarterly Update
24/10/19PRICE SENSITIVE download Created with Sketch. 302.11KB
ACW Annual Report to shareholders
22/10/19 download Created with Sketch. 1.79MB
ACW Notice of Annual General Meeting/Proxy Form
22/10/19 download Created with Sketch. 794.26KB
ACW Cognitive improvement demonstrated with Xanamem
01/10/19PRICE SENSITIVE download Created with Sketch. 2.63MB
ACW Actinogen Medical Conference Call
30/09/19 download Created with Sketch. 132.63KB
ACW Notification of 2019 Annual General Meeting Date
27/09/19 download Created with Sketch. 130.78KB
ACW Trading Halt
27/09/19PRICE SENSITIVE download Created with Sketch. 232.45KB
ACW Appendix 4G
16/08/19 download Created with Sketch. 101.3KB
ACW Appendix 4E & Annual Report
16/08/19PRICE SENSITIVE download Created with Sketch. 1.79MB
ACW June 2019 Quarterly Update
30/07/19PRICE SENSITIVE download Created with Sketch. 237.23KB
ACW Clinical Development and Scientific Conference Update
03/07/19 download Created with Sketch. 141.45KB
ACW Xanamen Clinical Development & Investor Update
26/06/19PRICE SENSITIVE download Created with Sketch. 2.47MB
ACW Actingoen Medical participating in the BIO 2019 Convention
03/06/19 download Created with Sketch. 142.86KB
ACW XanaHES Trial to Continue
29/05/19PRICE SENSITIVE download Created with Sketch. 142.12KB
ACW Ceasing to be a substantial holder
10/05/19 download Created with Sketch. 181.92KB
ACW Ceasing to be a substantial holder from AEF
08/05/19 download Created with Sketch. 430.49KB
ACW Phase II Alzheimer's Disease Trial - results
07/05/19PRICE SENSITIVE download Created with Sketch. 145.16KB
ACW Trading Halt
03/05/19PRICE SENSITIVE download Created with Sketch. 234.39KB
ACW Actinogen Updated Investor Presentation
01/05/19 download Created with Sketch. 3.53MB
ACW March 2019 Quarterly Update
24/04/19PRICE SENSITIVE download Created with Sketch. 295.74KB
ACW Change in substantial holding
23/04/19 download Created with Sketch. 200.93KB
ACW Lapse of Options
15/04/19 download Created with Sketch. 133.07KB
ACW Appendix 3Y-Mr Malcolm McComas
12/04/19 download Created with Sketch. 25.82KB
ACW Appendix 3B
12/04/19 download Created with Sketch. 156.69KB
ACW New Clinical Development Opportunities for Xanamem
10/04/19PRICE SENSITIVE download Created with Sketch. 141.79KB
ACW Cleansing Notice
04/04/19 download Created with Sketch. 100.42KB
ACW Appendix 3B
04/04/19 download Created with Sketch. 153.44KB
ACW Appendix 3X-Malcolm McComas
04/04/19 download Created with Sketch. 66.89KB
ACW Actinogen Medical appoints new Non-Executive Director
04/04/19 download Created with Sketch. 134.24KB
ACW DSMB again reaffirms XanADu trial to continue without change
26/03/19PRICE SENSITIVE download Created with Sketch. 135.23KB
ACW Change in substantial holding (Replacement Form 604)
22/03/19 download Created with Sketch. 274.83KB
ACW Change in substantial holding
22/03/19 download Created with Sketch. 244.57KB
ACW Actinogen Updated Investor Presentation
21/03/19 download Created with Sketch. 2.88MB
ACW Appendix 3B
19/03/19 download Created with Sketch. 159.03KB
ACW Becoming a substantial holder
14/03/19 download Created with Sketch. 304.67KB
ACW Amended-Notification of Expiry of Listed Options
04/03/19 download Created with Sketch. 205.14KB
ACW Notification of Expiry of Listed Options
27/02/19 download Created with Sketch. 154.77KB
ACW Appendix 4D & Half-Year Financial Statements
22/02/19PRICE SENSITIVE download Created with Sketch. 671.9KB
ACW 1st participant dosed in important new Xanamem study-XanaHES
11/02/19PRICE SENSITIVE download Created with Sketch. 137.29KB
ACW Appendix 3B
04/02/19 download Created with Sketch. 153.92KB
ACW December 2018 Quarterly Update
29/01/19PRICE SENSITIVE download Created with Sketch. 237.64KB
ACW ACW Presents at SACHS Neuroscience Forum during JPM Week
07/01/19 download Created with Sketch. 2.79MB
ACW Appendix 3Y-Dr George Morstyn
13/12/18 download Created with Sketch. 26.42KB
ACW Appendix 3Y-Dr Bill Ketelbey
13/12/18 download Created with Sketch. 26.34KB
ACW Appendix 3y-Dr Geoff Brooke
13/12/18 download Created with Sketch. 26.62KB
ACW Appendix 3B
13/12/18 download Created with Sketch. 155.42KB
ACW Cleansing Notice
30/11/18 download Created with Sketch. 99.75KB
ACW Appendix 3B-Exercise of Options
30/11/18 download Created with Sketch. 159.29KB
ACW Appendix 3Z-Dr Jason Loveridge
28/11/18 download Created with Sketch. 26.74KB
ACW Retirement of Dr Jason Loveridge as a Non-Executive Director
28/11/18 download Created with Sketch. 131.66KB
ACW Results of Annual General Meeting
28/11/18 download Created with Sketch. 189.04KB
ACW Managing Director's AGM Presentation
28/11/18 download Created with Sketch. 1.17MB
ACW Chairman's AGM Address
28/11/18 download Created with Sketch. 89.83KB
ACW Final patient enrolled in landmark Alzheimer's trial-XanADu
26/11/18PRICE SENSITIVE download Created with Sketch. 132.3KB
ACW Actinogen updated investor presentation
26/11/18 download Created with Sketch. 2.82MB
ACW Cleansing Notice
14/11/18 download Created with Sketch. 99.78KB
ACW Appendix 3B-Exercise of Options
14/11/18 download Created with Sketch. 159.68KB
ACW Supportive research highlights cortisol hypothesis
08/11/18 download Created with Sketch. 179.93KB
ACW September 2018 Quarterly Update
31/10/18PRICE SENSITIVE download Created with Sketch. 238.76KB
ACW Vesting Conditions Met
31/10/18 download Created with Sketch. 130.33KB
ACW Actinogen to be showcased at AusBiotech Invest 2018
30/10/18 download Created with Sketch. 694.34KB
ACW Enrolment target achieved for major Alzheimer's trial-XanADu
29/10/18 download Created with Sketch. 132.73KB
ACW XanADu trial to be presented at global Alzheimer conference
24/10/18 download Created with Sketch. 138.03KB
ACW Annual Report to Shareholders
23/10/18 download Created with Sketch. 1.56MB
ACW Notice of Annual General Meeting/Proxy Form
23/10/18 download Created with Sketch. 463.61KB
ACW Recruitment to close for important Alzheimer's trial-XanADu
22/10/18PRICE SENSITIVE download Created with Sketch. 134.26KB
ACW Actinogen to be showcased at key conferences
17/10/18 download Created with Sketch. 1.24MB
ACW Becoming a substantial holder from AEF
16/10/18 download Created with Sketch. 440.95KB
ACW R&D Tax Rebate Received Totalling $3.15 Million
10/10/18PRICE SENSITIVE download Created with Sketch. 138.04KB
ACW Notification of 2018 Annual General Meeting Date
28/09/18 download Created with Sketch. 127.19KB
ACW Cleansing Notice
18/09/18 download Created with Sketch. 99.77KB
ACW Appendix 3B-Exercise of Options
18/09/18 download Created with Sketch. 160.45KB
ACW Actinogen to Present to Investors in Singapore & Sydney
11/09/18 download Created with Sketch. 1.56MB
ACW Appendix 4G
29/08/18 download Created with Sketch. 109.87KB
ACW Appendix 4E & Financial Statements
29/08/18PRICE SENSITIVE download Created with Sketch. 1.56MB
(20min delay)
Last
2.8¢
Change
0.001(3.70%)
Mkt cap ! $31.25M
Open High Low Value Volume
2.8¢ 2.8¢ 2.8¢ $23.45K 834.2K

Buyers (Bids)

No. Vol. Price($)
2 187000 2.8¢
 

Sellers (Offers)

Price($) Vol. No.
2.9¢ 567796 1
View Market Depth
Last trade - 15.56pm 18/09/2020 (20 minute delay) ?
(live)
Last
2.9¢
  Change
0.001 ( 3.57 %)
Open High Low Volume
2.8¢ 2.9¢ 2.8¢ 635990
Last updated 15.19pm 18/09/2020 (live) ?
ACW (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.